Ginny Mason: Clinical Trials are Challenging to Complete in the Best of Circumstances
Ginny Mason, Executive Director of the Inflammatory Breast Cancer Research Foundation, shared a post on LinkedIn by IU Simon Comprehensive Cancer Center, adding:
“Clinical Trials are challenging to complete in the best of circumstances.
When you add travel, limited resources, and additional barriers, it can be difficult to accrue adequate numbers of patients.”
Quoting IU Simon Comprehensive Cancer Center‘s post:
“The cancer center’s Patrick Loehrer, MD, and colleagues published a new article in JAMA Network Open.”
Title: Barriers and Opportunities for Cancer Clinical Trials in Low- and Middle-Income Countries
Journal: JAMA Network Open
Authors: Linsey Eldridge, Nina R. Goodman, Amina Chtourou, Annette Galassi, Cecilia Monge, Mishka Kohli Cira, Paul C. Pearlman, Patrick J. Loehrer Sr, Satish Gopal, Ophira Ginsburg
More posts featuring Ginny Mason on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023